BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 17464270)

  • 1. Pitfalls in PET/CT interpretation.
    Cook GJ
    Q J Nucl Med Mol Imaging; 2007 Sep; 51(3):235-43. PubMed ID: 17464270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-ray-based attenuation correction for positron emission tomography/computed tomography scanners.
    Kinahan PE; Hasegawa BH; Beyer T
    Semin Nucl Med; 2003 Jul; 33(3):166-79. PubMed ID: 12931319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin.
    Zhang M; Jiang X; Zhang M; Xu H; Zhai G; Li B
    J Nucl Med; 2009 Apr; 50(4):506-12. PubMed ID: 19289438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET and PET/CT in pediatric oncology.
    Jadvar H; Connolly LP; Fahey FH; Shulkin BL
    Semin Nucl Med; 2007 Sep; 37(5):316-31. PubMed ID: 17707239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. F-18 FDG PET/CT in the management of thyroid cancer.
    Iagaru A; Kalinyak JE; McDougall IR
    Clin Nucl Med; 2007 Sep; 32(9):690-5. PubMed ID: 17710020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor volume assessment by 18F-FDG PET/CT in patients with oral cavity cancer with dental artifacts on CT or MR images.
    Baek CH; Chung MK; Son YI; Choi JY; Kim HJ; Yim YJ; Ko YH; Choi J; Cho JK; Jeong HS
    J Nucl Med; 2008 Sep; 49(9):1422-8. PubMed ID: 18703597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation.
    Wykrzykowska J; Lehman S; Williams G; Parker JA; Palmer MR; Varkey S; Kolodny G; Laham R
    J Nucl Med; 2009 Apr; 50(4):563-8. PubMed ID: 19289431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated PET-CT for the characterization of adrenal gland lesions in cancer patients: diagnostic efficacy and interpretation pitfalls.
    Chong S; Lee KS; Kim HY; Kim YK; Kim BT; Chung MJ; Yi CA; Kwon GY
    Radiographics; 2006; 26(6):1811-24; discussion 1824-6. PubMed ID: 17102052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer.
    Anjos DA; Etchebehere EC; Ramos CD; Santos AO; Albertotti C; Camargo EE
    J Nucl Med; 2007 May; 48(5):764-70. PubMed ID: 17475965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data.
    Martinez-Möller A; Souvatzoglou M; Delso G; Bundschuh RA; Chefd'hotel C; Ziegler SI; Navab N; Schwaiger M; Nekolla SG
    J Nucl Med; 2009 Apr; 50(4):520-6. PubMed ID: 19289430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG PET and 18F-FDG PET/CT for assessing response to therapy in esophageal cancer.
    Krause BJ; Herrmann K; Wieder H; zum Büschenfelde CM
    J Nucl Med; 2009 May; 50 Suppl 1():89S-96S. PubMed ID: 19380406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of myocardial perfusion 82Rb PET performed with CT- and transmission CT-based attenuation correction.
    Slomka PJ; Le Meunier L; Hayes SW; Acampa W; Oba M; Haemer GG; Berman DS; Germano G
    J Nucl Med; 2008 Dec; 49(12):1992-8. PubMed ID: 19038996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fever of unknown origin: the role of 18F-FDG PET/CT.
    Keidar Z; Gurman-Balbir A; Gaitini D; Israel O
    J Nucl Med; 2008 Dec; 49(12):1980-5. PubMed ID: 18997040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fat necrosis mimicking B-cell lymphoma: a PET/CT and FDG study.
    Belakhlef A; Jani C; Church C; Fraser R; Lakhanpal S
    Clin Nucl Med; 2008 Apr; 33(4):271-2. PubMed ID: 18356666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography/computed tomography: protocol issues and options.
    Blodgett TM; McCook BM; Federle MP
    Semin Nucl Med; 2006 Apr; 36(2):157-68. PubMed ID: 16517237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Giant cell arteritis on 18F-FDG PET/CT.
    Heston TF; Szabo Z
    Clin Physiol Funct Imaging; 2009 Sep; 29(5):382-4. PubMed ID: 19522856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
    Bastiaannet E; Wobbes T; Hoekstra OS; van der Jagt EJ; Brouwers AH; Koelemij R; de Klerk JM; Oyen WJ; Meijer S; Hoekstra HJ
    J Clin Oncol; 2009 Oct; 27(28):4774-80. PubMed ID: 19720925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET/CT for the staging and follow-up of patients with malignancies.
    Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G
    Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic value of 18F-FDG PET/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus.
    Guo H; Zhu H; Xi Y; Zhang B; Li L; Huang Y; Zhang J; Fu Z; Yang G; Yuan S; Yu J
    J Nucl Med; 2007 Aug; 48(8):1251-8. PubMed ID: 17631554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.